gip glp 1 receptor agonist drugs Schematic illustration of monoagonists, dual agonists and triple Dual and Triple Gut Peptide

With the rising incidence of obesity, there is a growing demand for new therapies which can effectively manage body weight and improve health

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk

Berberine is not a GLP-1 agonist, though both compounds influence metabolic pathways

Chilean AI-led food tech startup NotCo has unveiled a botanical GLP Booster powder that uses food as a natural Ozempic alternative.

Social media is packed with claims of finding natures Ozempic. How legitimate are these claims

They are primarily used in the management of type 2 diabetes (T2D).